OpenAI for Science is an initiative through which the company addresses scientists – and certainly wants to retain them. Now OpenAI is launching Prism, an AI-based workspace for scientific writing.

OpenAI is releasing a new app called Prism today, and it hopes it does for science what coding agents like Claude Code and its own Codex platform have done for programming. Prism builds on Crixet, a ...

Jan 15 (Reuters) - Boston Scientific said on Thursday ‌it will buy Penumbra ‌in a deal valued at about $14.5 billion to ⁠expand ‌its vascular pipeline. The deal values ‍Penumbra at $374 per share, a ...

The companies will work together to help pharmaceutical organizations improve efficiency and deliver better outcomes for patients. BOSTON, Jan. 13, 2026 /PRNewswire/ -- TetraScience, the Scientific ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Boston Scientific said Monday it has agreed to acquire ...

A new paper published in The Gerontologist provides the most comprehensive scientific response to date addressing recent critiques of the so-called "Blue Zones," regions of the world known for ...

We preselected all newsletters you had before unsubscribing.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Boston Scientific has been ...

For me, buying a publicly traded stock is no different than buying an interest in a private business. In either case, I would only invest in a company that’s well-managed, with a valuable product line ...

Should you believe the findings of scientific studies? Amid current concerns about the public's trust in science, old arguments are resurfacing that can sow confusion. As a statistician involved in ...

Crypto miner Core Scientific on Thursday ended a deal for its sale to CoreWeave after shareholders voted against the proposal, marking the culmination of months-long investor and proxy campaigns ...

CoreWeave CEO Michael Intrator said the company would not raise its acquisition price for Bitcoin miner Core Scientific. Intrator told CNBC that Core Scientific is a "nice to have, not a need to have.